CDC73 and neoplasm: We anticipate an expansion of parafibromin staining as a mandatory tool in the assessment of HJT-associated tumours (confirmed or suspected to be related to CDC73 spectrum); its exact clinical relevance as a contributor to the tumour growth and relapse/recurrence or as every day prognostic marker is yet to be defined.